Most importantly, mice bearing Park2 loss developed tumor types, including hystiocytic sarcoma, multiple myeloma, and osteosarcoma in spine (Figures S7C and S7D), that have not been previously described for the Pten+/− mice. Here, PRKN is linked to osteosarcoma.